These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25134604)

  • 41. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Viral hepatitis B, C and HIV infection in Croatian prisons.
    Burek V; Horvat J; Butorac K; Mikulić R
    Epidemiol Infect; 2010 Nov; 138(11):1610-20. PubMed ID: 20202285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Injecting drug use among gay and bisexual men in Sydney: prevalence and associations with sexual risk practices and HIV and hepatitis C infection.
    Lea T; Mao L; Bath N; Prestage G; Zablotska I; de Wit J; Holt M
    AIDS Behav; 2013 May; 17(4):1344-51. PubMed ID: 23321949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender.
    Lidman C; Norden L; Kåberg M; Käll K; Franck J; Aleman S; Birk M
    Scand J Infect Dis; 2009; 41(9):679-84. PubMed ID: 19521924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Jailbreak Health Project--incorporating a unique radio programme for prisoners.
    Minc A; Butler T; Gahan G
    Int J Drug Policy; 2007 Oct; 18(5):444-6. PubMed ID: 17854735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999.
    Thorpe LE; Ouellet LJ; Levy JR; Williams IT; Monterroso ER
    J Infect Dis; 2000 Dec; 182(6):1588-94. PubMed ID: 11069228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk Factors and predictors of human immunodeficiency virus infection among injection drug users.
    Backmund M; Meyer K; Henkel C; Reimer J; Wächtler M; Schütz CG
    Eur Addict Res; 2005; 11(3):138-44. PubMed ID: 15990431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevalence of chronic hepatitis B virus (HBV) infection in closed communities and risk behaviour].
    Nazare C; Gîrleanu I; Cojocariu-Salloum C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):325-30. PubMed ID: 21870718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C and injecting drug use in prisons.
    McBride AJ; Ali IM; Clee W
    BMJ; 1994 Oct; 309(6958):876. PubMed ID: 7524876
    [No Abstract]   [Full Text] [Related]  

  • 50. Risk Factors for a Positive Hepatitis C Status in Fishermen in Kuantan Malaysia.
    Lall P; Saifi R; Baggio D; Schoenberger SF; Choo M; Gilbert L; West B; El-Bassel N; Kamarulzaman A
    Asia Pac J Public Health; 2019 Apr; 31(3):227-237. PubMed ID: 30983376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding correlates of hepatitis C virus infection among homeless recently paroled men.
    Nyamathi A; Salem BE; Marlow E; Zhang S; Yadav K
    J Forensic Nurs; 2013; 9(3):161-70. PubMed ID: 24158154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C surveillance among youth and young adults in New York City, 2009-2013.
    Prussing C; Bornschlegel K; Balter S
    J Urban Health; 2015 Apr; 92(2):387-99. PubMed ID: 25450518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Longitudinal Study of Multiple Drug Use and Overdose Among Young People Who Inject Drugs.
    Riley ED; Evans JL; Hahn JA; Briceno A; Davidson PJ; Lum PJ; Page K
    Am J Public Health; 2016 May; 106(5):915-7. PubMed ID: 26985620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A cruel and unusual punishment.
    Crofts N
    Med J Aust; 1997 Feb; 166(3):116. PubMed ID: 9059429
    [No Abstract]   [Full Text] [Related]  

  • 55. Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs.
    Grebely J; Bruggmann P; Treloar C; Byrne J; Rhodes T; Dore GJ;
    Int J Drug Policy; 2015 Oct; 26(10):893-8. PubMed ID: 26254497
    [No Abstract]   [Full Text] [Related]  

  • 56. High rates of general practice attendance by former prisoners: a prospective cohort study.
    Carroll M; Spittal MJ; Kemp-Casey AR; Lennox NG; Preen DB; Sutherland G; Kinner SA
    Med J Aust; 2017 Jul; 207(2):75-80. PubMed ID: 28701128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C prevalence among people who inject drugs in Hungary.
    Gyarmathy VA; Sárosi P
    Lancet Infect Dis; 2015 Nov; 15(11):1261-2. PubMed ID: 26531034
    [No Abstract]   [Full Text] [Related]  

  • 58. Age cohort differences in illicit drug use and hepatitis C among African American substance users.
    Whitehead NE; Hearn L; Trenz RC; Burrell LE; Latimer WW
    J Addict Dis; 2014; 33(4):314-21. PubMed ID: 25299749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study size and documentation to detect injection-related hepatitis C in prison.
    Gore SM; Bird AG
    QJM; 1998 May; 91(5):353-7. PubMed ID: 9709469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can hepatitis C transmission be reduced in Australian prisons?
    Dolan KA
    Med J Aust; 2001 Apr; 174(8):378-9. PubMed ID: 11346077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.